These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25854900)

  • 1. Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective.
    Ilyas A; Hashim Z; Zarina S
    Mol Cell Biochem; 2015 Jul; 405(1-2):53-61. PubMed ID: 25854900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alendronate and FTI-277 combination as a possible therapeutic approach for hepatocellular carcinoma: An in vitro study.
    Ilyas A; Hashim Z; Channa IS; Zarina S
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):241-250. PubMed ID: 29627155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
    Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
    Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
    Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
    Khan GN; Kim EJ; Shin TS; Lee SH
    Anticancer Res; 2017 May; 37(5):2355-2364. PubMed ID: 28476801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7.
    Sajadian SO; Tripura C; Samani FS; Ruoss M; Dooley S; Baharvand H; Nussler AK
    Clin Epigenetics; 2016; 8():46. PubMed ID: 27134688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Azacytidine promotes HCC cell metastasis by up-regulating RDH16 expression.
    Le L; Qipeng W; Chunmeng M; Hasnat M; Luyong Z; Zhenzhou J; Qinwei Y
    Eur J Pharmacol; 2023 Jul; 950():175736. PubMed ID: 37116561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells.
    Wu WR; Zhang R; Shi XD; Yi C; Xu LB; Liu C
    Oncol Rep; 2016 Jul; 36(1):181-8. PubMed ID: 27221981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.
    Acun T; Demir K; Oztas E; Arango D; Yakicier MC
    OMICS; 2015 Apr; 19(4):220-9. PubMed ID: 25831062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
    Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells.
    Wang RC; Huang CY; Pan TL; Chen WY; Ho CT; Liu TZ; Chang YJ
    PLoS One; 2015; 10(10):e0139232. PubMed ID: 26431426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation.
    Bodzin AS; Wei Z; Hurtt R; Gu T; Doria C
    J Cell Physiol; 2012 Jul; 227(7):2947-52. PubMed ID: 21959795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
    Ou Y; Zhai D; Wu N; Li X
    Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.
    Qiao B; Wang J; Xie J; Niu Y; Ye S; Wan Q; Ye Q
    Int J Mol Med; 2012 May; 29(5):832-40. PubMed ID: 22344546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.
    Xi S; Peng Y; Minuk GY; Shi M; Fu B; Yang J; Li Q; Gong Y; Yue L; Li L; Guo J; Peng Y; Wang Y
    J Ethnopharmacol; 2016 Aug; 190():1-12. PubMed ID: 27235019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
    Chan DW; Lee JM; Chan PC; Ng IO
    Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine.
    Wang X; Wang N; Li H; Liu M; Cao F; Yu X; Zhang J; Tan Y; Xiang L; Feng Y
    Int J Mol Sci; 2016 Apr; 17(4):577. PubMed ID: 27092498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
    Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ
    Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.